Anpario plc (LON:ANP – Get Free Report) insider Marc Wilson bought 3,778 shares of the stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average cost of GBX 398 ($5.13) per share, with a total value of £15,036.44 ($19,396.85).
Anpario Stock Performance
Shares of Anpario stock opened at GBX 325 ($4.19) on Friday. Anpario plc has a 52 week low of GBX 229.50 ($2.96) and a 52 week high of GBX 488.55 ($6.30). The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The stock has a market capitalization of £55.45 million, a price-to-earnings ratio of 17.95 and a beta of 0.58. The firm has a fifty day moving average of GBX 426.24 and a two-hundred day moving average of GBX 377.39.
Anpario (LON:ANP – Get Free Report) last released its earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.37) earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. As a group, equities research analysts predict that Anpario plc will post 23.5757801 EPS for the current year.
Anpario Increases Dividend
Analyst Ratings Changes
Several equities analysts recently issued reports on ANP shares. Canaccord Genuity Group raised their price target on Anpario from GBX 380 ($4.90) to GBX 500 ($6.45) and gave the company a “buy” rating in a report on Tuesday, January 14th. Shore Capital reaffirmed a “house stock” rating on shares of Anpario in a research note on Monday, March 31st.
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Recommended Stories
- Five stocks we like better than Anpario
- What Are Trending Stocks? Trending Stocks Explained
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Compound Interest and Why It Matters When Investing
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.